Welcome to the Kids' Library!

Assessment of sponsors' materials under the temporary Medicare-approved drug discount card program.

United States. Department of Health and Human Services. Office of Inspector General, author.
[Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 2005. 2005

Capitalizing a cure : how finance controls the price and value of medicines

Roy, Victor, 1986- author.
Oakland, California : University of California Press, [2023] 2023

CBO's model of drug price negotiations under the Elijah E. Cummings Lower Drug Costs Now Act

Adams, Christopher P., author.
Washington, D.C. : Congressional Budget Office, 2021. 2021

CBO's simulation model of new drug development

Adams, Christopher P., author.
Washington, D.C. : Congressional Budget Office, 2021. 2021

Closing the coverage gap Medicare prescription drugs are becoming more affordable.

[Baltimore, Maryland] : Centers for Medicare & Medicaid Services, [2015] 2015

Comparing drug reimbursement : Medicare and Department of Veterans Affairs.

United States. Department of Health and Human Services. Office of Inspector General, author.
[Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 1998. 1998

Competition and the cost of Medicare's prescription drug program.

Cook, Anna, author.
[Washington, D.C.] : Congress of the United States, Congressional Budget Office, 2014. 2014

Coverage and pricing of drugs that can be covered under Part B and Part D final report

Hargrave, Elizabeth.
Washington, DC : MedPAC, [2007] 2007

The CREATES Act of 2019 and lowering drug prices : legal background and overview

Shen, Wen S., author.
[Washington, D.C.] : Congressional Research Service, 2019- 2019

Creating and Restoring Equal Access to Equivalent Samples Act of 2019 : report (to accompany H.R. 96

United States. Congress. House. Committee on Energy and Commerce, author.
[Washington, D.C.] : [U.S. Government Publishing Office], [2019]- 2019

Deficiencies in the 340B drug discount program's database.

United States. Department of Health and Human Services. Office of Inspector General, author.
[Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 2004. 2004

Deficiencies in the oversight of the 340B drug pricing program.

United States. Department of Health and Human Services. Office of Inspector General, author.
[Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 2005. 2005

Designing a twenty-first century Medicare prescription drug benefit : hearing before the Subcommitte

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O. [Congressional Sales Office], 2003. 2003

DOD and VA pharmacy progress and remaining challenges in jointly buying and mailing out drugs : repo

United States. General Accounting Office.
[Washington, D.C.] : The Office, [2001] 2001

Drug prices effects of opening federal supply schedule for pharmaceuticals are uncertain : report to

United States. General Accounting Office.
Washington, D.C. : The Office ; Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20884-6015) : The Office [distributor, 1997] 1997

Drug prices paid by DOD and VA are, on average, lower than those certified to HCFA as best price

United States. General Accounting Office.
Washington, DC : The Office, [2000] 2000

Drug pricing and the law : regulatory exclusivities

Ward, Erin H., author.
[Washington, D.C.] : Congressional Research Service, 2019- 2019

Drug pricing manufacturer discounts in the 340B program offer benefits, but federal oversight needs

United States. Government Accountability Office.
[Washington, D.C.] : U.S. Govt. Accountability Office, [2011] 2011

Drug shortage crisis : lives are in the balance : hearing before the Subcommittee on Health Care, Di

United States. Congress. House. Committee on Oversight and Government Reform. Subcommittee on Health Care, District of Columbia, Census, and the National Archives.
Washington : U.S. G.P.O. : for sale by the Supt. of Docs., U.S. G.P.O., 2012. 2012

Drug shortages : causes, FDA authority, and policy options

Bodie, Agata, author.
[Washington, D.C.] : Congressional Research Service, 2018- 2018

Drug shortages, public health threat continues, despite efforts to help ensure product availability

United States. Government Accountability Office, issuing body.
[Washington, D.C.] : United States Government Accountability Office, 2014. 2014

Drug shortages : why they happen and what they mean : hearing before the Committee on Finance, Unite

United States. Congress. Senate. Committee on Finance, author.
Washington : U.S. Government Printing Office, 2011. 2011

Economic analysis of the causes of drug shortages.

Washington, DC : Office of the Assistant Secretary for Planning and Evaluation, Office of Science and Data Policy, U.S. Department of Health and Human Services, 2011. 2011

The effect of generic drug competition on generic drug prices during the Hatch-Waxman 180-day exclus

Olson, Luke M., author.
Washington, DC : Bureau of Economics, Federal Trade Commission, 2013. 2013

Enhancing Medicare for the 21st century a prescription benefit for seniors : hearing before the Spec

United States. Congress. Senate. Special Committee on Aging.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2004. 2004

Excessive Medicare payments for prescription drugs.

United States. Department of Health and Human Services. Office of Inspector General, author.
[Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 1997. 1997

FDA and drug prices : facilitating access to generic drugs

Bodie, Agata, author.
[Washington, D.C.] : Congressional Research Service, 2018- 2018

Full committee hearing on Medicaid drug reimbursements : are CMS cuts bad medicine for small busines

United States. Congress. House. Committee on Small Business.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2007. 2007

Generic pharmaceuticals : marketplace access and consumer issues : hearing before the Committee on C

United States. Congress. Senate. Committee on Commerce, Science, and Transportation.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2004. 2004

Improvements to the food at home, shelter, and prescription drug indexes in the U.S. consumer price

Armknecht, Paul A., 1945-
[Washington, D.C.] : U.S. Dept. of Labor, Bureau of Labor Statistics, Office of Prices and Living Conditions, [1995] 1995

International prescription drug parity : are Americans being protected or gouged? : hearing before t

United States. Congress. House. Committee on Government Reform. Subcommittee on Human Rights and Wellness.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O. [Congressional Sales Office], 2003. 2003

International trade and pharmaceuticals : joint hearing before the Subcommittee on International Tra

United States. Congress. Senate. Committee on Finance. Subcommittee on International Trade.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2004. 2004

Internet pharmacy and drug importation exploring risks and benefits : hearing before the Special Com

United States. Congress. Senate. Special Committee on Aging.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2005. 2005

Is the U.S Department of Veterans Affairs meeting the pharmaceutical needs of veterans? hearing befo

United States. Congress. House. Committee on Veterans' Affairs. Subcommittee on Health.
Washington : U.S. G.P.O., 2010. 2010

Issues in designing a prescription drug benefit for Medicare.

[Washington, D.C.] : Congress of the United States, Congressional Budget Office, [2002] 2002

Lean biomanufacturing : creating value through innovative bioprocessing approaches

Smart, Nigel J., author.
Oxford ; Philadelphia : Woodhead Publishing, 2013. 2013

Lessons learned : the Department of Veterans Affairs prescription drug purchasing program : hearing

United States. Congress. House. Committee on Government Reform. Subcommittee on National Security, Veterans Affairs, and International Relations.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O. [Congressional Sales Office], 2003. 2003

Looks can be deceiving the medicine you buy from outside the United States may be unsafe or ineffect

[Washington, D.C.] : U.S. Dept. of Health and Human Services, Food and Drug Administration, [2004] 2004

Medicare payments for covered outpatient drugs exceed providers' cost.

United States. General Accounting Office.
[Washington, D.C.] : U.S. General Accounting Office, [2001] 2001

Medicare Part D coverage gap discount program effects and brand-name drug price trends : report to c

United States. Government Accountability Office.
[Washington, D.C.] : U.S. Govt. Accountability Office, [2012] 2012

Medicare payments for currently covered prescription drugs hearing before the Subcommittee on Health

United States. Congress. House. Committee on Ways and Means. Subcommittee on Health.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O. [Congressional Sales Office], 2003. 2003

Medicare prescription drug benefit : review and oversight : hearing before the Committee on Finance,

United States. Congress. Senate. Committee on Finance.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2007. 2007

Memorandum report : Medicare Part D pharmacy discounts for 2008.

United States. Department of Health and Human Services. Office of Inspector General, author.
Washington, D.C. : Department of Health and Human Services, Office of Inspector General, 2010. 2010

The opioid epidemic and the U.S. labor market

Donovan, Sarah A., author.
[Washington, D.C.] : Congressional Research Service, 2018- 2018

Outpatient prescribed medicines a comparison of use and expenditures, 1987 and 2001

Pancholi, Mamatha.
[Rockville, Md.] : Medical Expenditure Panel Survey, Agency for Healthcare Research and Quality, [2004] 2004

Outpatient prescription medicines a comparison of expenditures by household-reported condition, 1987

Stagnitti, Marie N.
[Rockville, Md.] : Medical Expenditure Panel Survey, Agency for Healthcare Research and Quality, [2004] 2004

Paid to prescribe? exploring the relationship between doctors and the drug industry : hearing before

United States. Congress. Senate. Special Committee on Aging.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2008. 2008

Patient safety and quality issues in end stage renal disease treatment : hearing before the Committe

United States. Congress. House. Committee on Ways and Means.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2007. 2007

Paying off generics to prevent competition with brand name drugs : should it be prohibited? : hearin

United States. Congress. Senate. Committee on the Judiciary.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2007. 2007

Pharmacy benefit managers early results on ventures with drug manufacturers : report to the Honorabl

United States. General Accounting Office.
Washington, D.C. : The Office ; Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20884-6015) : The Office [distributor, 1995] 1995